BamSEC and AlphaSense Join Forces
Learn More

Revance Therapeutics Inc.

NASDAQ: RVNC    
Share price (1/8/25): $3.39    
Market cap (1/8/25): $356 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 25 pages Amended and Restated Bylaws of Revance Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 21 pages Amended and Restated Bylaws of Revance Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 6 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 13 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.3
from S-1/A 13 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.4
from S-1 25 pages Amended and Restated Bylaws of Revance Therapeutics, Inc
12/34/56
EX-3.3
from S-1 27 pages Amended and Restated Bylaws of Revance Therapeutics, Inc
12/34/56
EX-3.2
from S-1 6 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.1
from S-1 21 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3
from DRS/A 21 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.4
from DRS/A 25 pages Amended and Restated Bylaws of Revance Therapeutics, Inc
12/34/56
EX-3.2
from DRS/A 6 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.1
from DRS/A 21 pages Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc
12/34/56
EX-3.3
from DRS 27 pages Amended and Restated Bylaws of Revance Therapeutics, Inc
12/34/56